Literature DB >> 28934750

Frontotemporal Dementia Caused by the P301L Mutation in the MAPT Gene: Clinicopathological Features of 13 Cases from the Same Geographical Origin in Barcelona, Spain.

Sergi Borrego-Écija1, Joana Morgado, Leire Palencia-Madrid, Oriol Grau-Rivera, Ramón Reñé, Isabel Hernández, Consuelo Almenar, Mircea Balasa, Anna Antonell, José Luis Molinuevo, Albert Lladó, Marian Martínez de Pancorbo, Ellen Gelpi, Raquel Sánchez-Valle.   

Abstract

BACKGROUND/AIMS: We identified and studied 13 patients carrying the P301L mutation in the MAPT gene from the same area (Baix Llobregat County) in Barcelona, Spain.
METHODS: The demographic and clinical features were reviewed retrospectively. Detailed neuropathological characterization was obtained in 9 subjects. To investigate the origin of the P301L mutation in these families, 20 single nucleotide polymorphisms (SNPs) in the MAPT gene were analyzed.
RESULTS: The mean age at disease onset was 51 years and the mean disease duration was 7 years. The most common initial symptoms were behavioral changes (54%), followed by language disturbances (31%) and memory loss (15%). 46% developed parkinsonism. Neuropathology showed an extensive neuronal and glial 4-repeat (4R) tauopathy with "mini-Pick"-like bodies in the dentate gyrus as the characteristic underlying pathology in all cases. In 1 subject, additional 4R globular glial inclusions were observed. All the mutation carriers showed the same haplotype for the SNPs analyzed, suggesting a common ancestor.
CONCLUSION: These findings suggest a relative homogeneous clinicopathological phenotype in P301L MAPT mutation carriers in our series. This phenotype might help in the differential diagnosis from other tauopathies and be a morphological hint for genetic testing. The haplotype analysis results suggest a founder effect of the P301L mutation in this area.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  FTDP-17; FTLD-tau; Frontotemporal lobar degeneration; Globular glial tauopathy; MAPT; P301L; Tauopathies

Mesh:

Substances:

Year:  2017        PMID: 28934750     DOI: 10.1159/000480077

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  14 in total

1.  Globular glial tauopathy caused by MAPT P301T mutation: clinical and neuropathological findings.

Authors:  M E Erro; M V Zelaya; M Mendioroz; R Larumbe; S Ortega-Cubero; J L Lanciego; A Lladó; T Cabada; T Tuñón; F García-Bragado; M R Luquin; P Pastor; I Ferrer
Journal:  J Neurol       Date:  2019-06-12       Impact factor: 4.849

2.  Isoform-specific patterns of tau burden and neuronal degeneration in MAPT-associated frontotemporal lobar degeneration.

Authors:  Harro Seelaar; David J Irwin; Lucia A A Giannini; Daniel T Ohm; Annemieke J M Rozemuller; Laynie Dratch; EunRan Suh; Vivianna M van Deerlin; John Q Trojanowski; Edward B Lee; John C van Swieten; Murray Grossman
Journal:  Acta Neuropathol       Date:  2022-09-06       Impact factor: 15.887

3.  Involvement of Oligodendrocytes in Tau Seeding and Spreading in Tauopathies.

Authors:  Isidro Ferrer; Meritxell Aguiló García; Margarita Carmona; Pol Andrés-Benito; Benjamin Torrejón-Escribano; Paula Garcia-Esparcia; José Antonio Del Rio
Journal:  Front Aging Neurosci       Date:  2019-05-28       Impact factor: 5.750

4.  Novel P397S MAPT variant associated with late onset and slow progressive frontotemporal dementia.

Authors:  Sergi Borrego-Écija; Anna Antonell; Joan Anton Puig-Butillé; Inmaculada Pericot; Carme Prat-Bravo; Maria Teresa Abellan-Vidal; Javier Mallada; Jaume Olives; Neus Falgàs; Rafael Oliva; Albert Lladó; Raquel Sánchez-Valle
Journal:  Ann Clin Transl Neurol       Date:  2019-07-17       Impact factor: 4.511

Review 5.  Cellular Biology of Tau Diversity and Pathogenic Conformers.

Authors:  Sang-Gyun Kang; Ghazaleh Eskandari-Sedighi; Lenka Hromadkova; Jiri G Safar; David Westaway
Journal:  Front Neurol       Date:  2020-11-12       Impact factor: 4.003

6.  Early anterior cingulate involvement is seen in presymptomatic MAPT P301L mutation carriers.

Authors:  Mica T M Clarke; Frédéric St-Onge; Jonathan D Rohrer; Robert Laforce; Jean-Mathieu Beauregard; Martina Bocchetta; Emily Todd; David M Cash
Journal:  Alzheimers Res Ther       Date:  2021-02-10       Impact factor: 6.982

Review 7.  Sexual Dimorphism in the 3xTg-AD Mouse Model and Its Impact on Pre-Clinical Research.

Authors:  Jessica L Dennison; Natalie R Ricciardi; Ines Lohse; Claude-Henry Volmar; Claes Wahlestedt
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

8.  Diverse, evolving conformer populations drive distinct phenotypes in frontotemporal lobar degeneration caused by the same MAPT-P301L mutation.

Authors:  Nathalie Daude; Chae Kim; Sang-Gyun Kang; Ghazaleh Eskandari-Sedighi; Tracy Haldiman; Jing Yang; Shelaine C Fleck; Erik Gomez-Cardona; Zhuang Zhuang Han; Sergi Borrego-Ecija; Serene Wohlgemuth; Olivier Julien; Holger Wille; Laura Molina-Porcel; Ellen Gelpi; Jiri G Safar; David Westaway
Journal:  Acta Neuropathol       Date:  2020-03-26       Impact factor: 17.088

9.  The role of MAPT gene in Chinese dementia patients: a P301L pedigree study and brief literature review.

Authors:  Shuang He; Shuai Chen; Ming-Rong Xia; Zhi-Kun Sun; Yue Huang; Jie-Wen Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2018-06-18       Impact factor: 2.570

10.  Familial globular glial tauopathy linked to MAPT mutations: molecular neuropathology and seeding capacity of a prototypical mixed neuronal and glial tauopathy.

Authors:  Isidro Ferrer; Pol Andrés-Benito; Maria Victoria Zelaya; Maria Elena Erro Aguirre; Margarita Carmona; Karina Ausín; Mercedes Lachén-Montes; Joaquín Fernández-Irigoyen; Enrique Santamaría; José Antonio Del Rio
Journal:  Acta Neuropathol       Date:  2020-01-06       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.